Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its target price raised by Royal Bank of Canada from $31.00 to $35.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. CDTX has been the subject of several other reports. Citizens Jmp started coverage on Cidara Therapeutics in […]
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its target price raised by Royal Bank of Canada from $31.00 to $35.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. CDTX has been the subject of several other reports. Citizens Jmp started coverage on Cidara Therapeutics in […]
